Novedades en colitis ulcerosa: a propósito de la aprobación en México de un nuevo mecanismo de acción anti-interleucinas 12 y 23 (ustekinumab)

by Francisca Martínez-Silva

Published in Revista Mexicana de Enfermedades Inflamatorias Inmunomediadas by Publicidad Permanyer, SLU.

2022

application/pdf 1.5 MB
file_gimpjhid7bb4lizay2tiwtp6zq www.imidsmexico.com (publisher)
web.archive.org (webarchive)

Preserved and Accessible

Type article-journal
Stage

published

Date 2022-12-20
Language es ^?

DOI 10.24875/imids.m22000026

Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L: 2696-6867

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: acff9232-118e-4ecf-a305-ec5320411fb9
API URL: JSON

Novedades en colitis ulcerosa: a propósito de la aprobación en México de un nuevo mecanismo de acción anti-interleucinas 12 y 23 (ustekinumab) release_c3qaeum335fs5psi3s5gxvr6la